Subscribe to our Newsletter and get informed about new publication regulary and special discounts for subscribers!

ILNS > ILNS Volume 23 > Studies on Biosynthesis of Silver Nanoparticles...
< Back to Volume

Studies on Biosynthesis of Silver Nanoparticles Using Rhizopus sp. and its Antibacterial Efficacy on E. coli MDR Strains

Full Text PDF


Nanotechnology is a field that is burgeoning day by day, making an impact in all spheres of human life. Biological methods of synthesis have paved way for the “greener synthesis” of nanoparticles and these have proven to be better methods due to slower kinetics, they offer better manipulation and control over crystal growth and their stabilization. In this context we have investigated extracellular biosynthesis of silver nanoparticles (AgNPs) using cell-free extract of Rhizopus spp.. Formation of AgNPs was indicated by the change in the colour of the cellfree extract from yellow to dark brown under static condition after 48 hrs of incubation. Characterization of AgNPs was carried out by UV-Vis Spectroscopy which gave sharp plasmon resonance peak at 429 nm corresponding to spherical shaped nanoparticles. Transmission electron microscopy (TEM) micrograph showed formation of well-dispersed AgNPs in the range of 25-50 nm. Scanning electron microscopy (SEM) showed the particles to be uniformly dispersed without agglomeration with smooth morphology. EDS showed the presence of elemental silver at 3kev. X-ray diffraction (XRD)-spectrum of the AgNPs exhibited 2θ¸ values corresponding to nanocrystal. These biosynthesized AgNPs were used to study their antimicrobial activity against Multi-drug resistant (MDR) E. coli strains, by Agar diffusion method. Zone of inhibition was measured. Synthesis of nanosized particles with antibacterial properties, which are called "nanoantibiotics", is of great interest in the development of new pharmaceutical products.


International Letters of Natural Sciences (Volume 23)
J. Hiremath et al., "Studies on Biosynthesis of Silver Nanoparticles Using Rhizopus sp. and its Antibacterial Efficacy on E. coli MDR Strains", International Letters of Natural Sciences, Vol. 23, pp. 27-35, 2014
Online since:
August 2014

Albrecht M.A., Evans C.W., Raston C.L., Green Chem. 8 (2006) 417-432.

Bhattacharya R., Mukherjee P., Adv drug deliv rev. 60 (2008) 1289-1306.

Kalishwaralal K., Deepak V., Ramkumarpandian S., Nellaiah H., Sangiliyandi G., Mater Lett. 62 (2008) 4411-4413.

Parashar U.K., Saxena S.P., Srivastava A., Dig J Nanomat Biostruct. 4 (2009) 159-166.

Sadhasivam S., Shanmugam P., Yun K., Colloids Surf. B. Biointerfaces. 81 (2010) 358-362.

Nanda A., Saravanan M., Nanomeicine. (2009) 5 (2009) 452-456.

Feng Q.L., et al, J Biomed. Mater. Res. 52 (2000) 662-668.

Kim J.S., et al., Nanomed. Nanotechnol. Biol. Med. 3 (2007) 95-101.

Kumar S.A., Abyaneh M.K., Gosavi S.W., Kulkarni S.K., Pasricha R., Ahmad A., Khan M.I., Biotechnol. Lett. 29 (2007)439-445.

Melaiye A., Young W.J., Expert. Opin. Ther. Pat. 15 (2005) 125-130.

Saravanan M., Venu A.K., Barik S.K., Colloids Surf. B. Biointerfaces. 88 (2011) 325-331.

Afreen Banu, Vandana Rathod, Ranganath E., Materials research bulletin. 46 (2011) 1417-1423.

Mukherjee P., Roy M., Mandal BP., Dey G.K. Mukherjee P.K., Ghatakj., Tyagi A.K., Kale S. P., IOP publishing Nanotechnology Journal 19 (2008) 075103.

Varshney R., Mishra A.N., Bhadauria S., Gaur M.S., Digest J. Nanomaterials and Biostructures. 4(2) (2009) 349-350.

Dattu Singh, Vandana Rathod, Shivaraj Ninganagouda, Jyothi H., Prema K., Journal of Pharmacy Research 7 (2013) 448-453.

Shivaraj Ninganagouda, Vandana Rathod, Jyoti H., Dattu Singh, Prema K., Manzoor-ul- Haq, Int J Pharma Bio Sci. 4(2) (2013) 222-229. ( Received 08 August 2014; accepted 14 August 2014 ).

Show More Hide
Cited By:
This article has no citations.